Evaluation of TruVivo, an All-Human Hepatocyte Model for Mechanistic DMPK Investigations
Join Diane Ramsden, PhD, and Lindsey Whaley, MS, for an inside look at TruVivo™, a novel all-human in vitro hepatocyte system developed by LifeNet Health LifeSciences.
Essential Bruker NMR Trainings 2023
Join Bruker experts online for 1 hour every month in this essential training program designed for NMR Scientists.
#ExpertAnswers: Ejvind Mørtz on Protein Analysis
Ejvind Mørtz discusses the benefits and applications of mass spectrometry (MS)-based host cell protein (HCP) analysis and why HCP ELISAs are insufficient for documenting product-related impurities.
Rethink your Impurity Analysis Strategy
In this webinar, Dr. Ejvind Mørtz discusses the benefits and applications of mass spectrometry (MS)-based host cell protein (HCP) analysis and why HCP ELISAs are insufficient for documenting product-related impurities. Watch to learn where to apply the assay in a typical process and what you gain from deploying it to your workflow.
#ExpertAnswers: Edward LeCluyse and Paul Gallant on a Novel Hepatic Triculture System
Edward LeCluyse and Paul Gallant discuss their novel all-human hepatic triculture system including its benefits and applications.
A Novel, All-Human Hepatic Triculture System
Join Edward LeCluyse and Paul Gallant as they offer insight into a novel, all-human hepatic triculture and how this unique system addresses the need for a convenient and human-relevant long-term hepatic culture.
Essential Bruker NMR Trainings 2022
Join Bruker experts for 1-hour every other week online for this essential training program designed for NMR Scientists.
Cutting Edge Conversations: Challenges in Sourcing Human Biosamples
Richard Kondo, McLean Collins, and Cathie G. Miller highlighted Episode 3 of the Cutting Edge Conversations series focused on innovations in the area of sourcing human biosamples for research. The event focused on sourcing human samples for research, including the value and necessity of working with human tissue during drug discovery, as well as some of the distinct challenges researchers face.
Translational Applications of MiniPDX: An In Vivo Organoid Assay in New Drug R&D
Join Dr. Danyi Wen as she describes a novel drug efficacy test using Patient Derived Xenograft (PDX) samples to measure drug efficacy and identify therapeutic candidates in personalized oncology treatments.
Academy of Surgical Research Virtual Annual Meeting 2021
Register to watch the on-demand 37th Academy of Surgical Research Virtual Meeting, a three-day exploration of surgical techniques, innovative research, and technology advancements.
#ExpertAnswers: Christian Schnell on Pharmacology Studies in Oncology Research
Christian Schnell, Associate Director of Oncology at Novartis in Basel, answers questions on PK-PD assessment and corresponding antitumor activity in pharmacology studies for oncology research.
Compound Delivery, PK-PD, & Validation Studies in Oncology Research
Dr. Christian Schnell describes his work involving implantable infusion pump studies in rodents and the advancement of pharmacological interventions in oncology research.
#ExpertAnswers: Matt Kaeberlein on Aging Science
Dr. Matt Kaeberlein, a Professor at the University of Washington School of Medicine, answers questions from a recent webinar that focused on translational geroscience, the drug rapamycin to target biological aging, and the Dog Aging Project.
Arxspan User Group Meeting 2021
The first ever virtual Arxspan User Group Meeting! Expert guests share the latest updates in Bruker’s laboratory data management solutions.
Targeting Biological Aging: A New Paradigm for 21st Century Medicine
During this webinar, Dr. Matt Kaeberlein provides an overview of translational geroscience, which he believes will become the paradigm for the practice of medicine in the 21st century. He also discusses his recent work with one such intervention, the drug rapamycin, and its potential to enhance healthspan in companion dogs and people.
Essential Bruker EPR Trainings 2021
Join Bruker for a six-part virtual training series on simulation and interpretation of EPR spectra.
Science of Aging: A Physiological & Translational Perspective
Science of Aging - A Physiological & Translational Perspective: A webinar series covering fundamentals, late-breaking research and novel discoveries in the field of aging science.
Essential Bruker NMR Trainings 2021
Join Bruker experts for 1-hour every other week online for this essential training program designed for NMR Scientists.
Bruker Americas NMR User Meeting 2020
A three-day virtual event for NMR scientists and industry professionals showcasing the latest in NMR technology from Bruker and select customer presentations
#ExpertAnswers: Fred Beasley on Obesity
Dr. Fred Beasley provides an overview of study design, criteria for defining your study aim and expert advice for selecting the ideal rodent model for your preclinical obesity research.
#ExpertAnswers: Chris Ward, Ramzi Khairallah & Sharon Hesterlee on Muscular Dystrophy
This episode of #ExpertAnswers features Dr. Chris Ward, Co-founder and scientific officer at myologica, Dr. Ramzi Khairallah, co-founder and president [...]
Academy of Surgical Research Virtual Annual Meeting 2020
Register for the 36th Annual Academy of Surgical Research Virtual Meeting to join surgical research professionals around the world in a two-day exploration of surgical techniques, research applications, technology advancements and industry trends.
COVID-19 – What’s NMR got to do with it?
Dr. Sharman explains the impact of using NMR for the quality control and release of drug molecules currently in shortage due to the Coronavirus pandemic.
Solid-state NMR Spectroscopy in Pharmaceutical Sciences from Drug Delivery to Formulation Development
Join Dr. Yongchao Su for an overview of the versatile roles of ssNMR in pharmaceutical development, providing a structural basis for the design of drug substances and products.
Considerations for Rigorous Pre-clinical Studies in Murine Muscular Dystrophy
Experts present key considerations in the design of rigorous preclinical studies in rodent models of muscular dystrophy, including animal model selection, assays and endpoints, and how your results can inform translation to the clinic.
